Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

European Journal of Surgical Oncology

Volumn 33, Issue 1, 2007, Pages 39-43

  Kreis, H ^a   Loehberg, C R ^a   Lux, M P ^a   Ackermann, S ^a   Lang, W ^a   Beckmann, M W ^a   Fasching, P A ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Breast cancer; Gynecological cancer; Port catheter; Quality of life

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CATHETER INFECTION; CENTRAL VEIN; CONTROLLED STUDY; COPING BEHAVIOR; ENDOMETRIUM CANCER; ESTHETICS; FEAR; FEMALE; GYNECOLOGIC CANCER; HEMATOMA; HEPARINIZATION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PAIN; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ENVIRONMENT; UTERINE CERVIX CANCER; VAGINA CANCER; VASCULAR ACCESS; VEIN CATHETERIZATION; VEIN THROMBOSIS; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33846504724     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.08.003     Document Type: Article

References (18)

1. Niederhuber J.E., Ensminger W., Gyves J.W., Liepman M., Doan K., and Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92 (1982) 706-712
2. Kock H.J., Pietsch M., Krause U., Wilke H., and Eigler F.W. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22 (1998) 12-16
3. Beckmann M.W., Lorenz C., and Dall P. Platzierung und Pflege von venösen Verweilkathetern und Portsystemen. Gynaekologe 33 (2000) 255-260
4. Biffi R., Martinelli G., Pozzi S., et al. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 24 (1999) 89-93
5. Champault G. Totally implantable catheters for cancer chemotherapy: French experience on 325 cases. Cancer Drug Deliv 3 (1986) 131-137
6. Bow E.J., Kilpatrick M.G., and Clinch J.J. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17 (1999) 1267
7. Goldhirsch A., Wood W.C., Gelber R.D., Coates A.S., Thurlimann B., and Senn H.J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21 (2003) 3357-3365
8. Borst C.G., de Kruif A.T., van Dam F.S., and de Graaf P.W. Totally implantable venous access ports-the patients' point of view. A quality control study. Cancer Nurs 15 (1992) 378-381
9. Broviac J.W., Cole J.J., and Scribner B.H. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 136 (1973) 602-606
10. Hickman R.O., Buckner C.D., Clift R.A., Sanders J.E., Stewart P., and Thomas E.D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148 (1979) 871-875
11. Holloway R.W., and Orr J.W. An evaluation of Groshong central venous catheters on a gynecologic oncology service. Gynecol Oncol 56 (1995) 211-217
12. Basford T.J., Poenaru D., and Silva M. Comparison of delayed complications of central venous catheters placed surgically or radiologically in pediatric oncology patients. J Pediatr Surg 38 (2003) 788-792
13. Schwarz R.E., Coit D.G., and Groeger J.S. Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol 7 (2000) 441-449
14. Schwarz R.E., Groeger J.S., and Coit D.G. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79 (1997) 1635-1640
15. Di Carlo I., Cordio S., La Greca G., et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136 (2001) 1050-1053
16. Verso M., and Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21 (2003) 3665-3675
17. Kurul S., Saip P., and Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 3 (2002) 684-692
18. Hartkamp A., van Boxtel A.J., Zonnenberg B.A., and Witteveen P.O. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 57 (2000) 215-223